Respiratory Muscle Training in Scleroderma

The aim of this study is to investigate the effects of IMT on respiratory muscle strength, pulmonary function tests, quality of life aerobic capacity, dyspnea, fatigue and physical activity level in scleroderma patients with ILD. The study will include 30 Scleroderma + ILD patients who are under follow-up in Fırat University Rheumatology Department. Patients will be randomly divided into two groups. High intensity intermittent inspiratory muscle training (H-IMT) will be applied to the respiratory muscle training group in addition to the exercise program. Respiratory muscle strength will be assessed by maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP); aerobic capacity will be assessed by exercise test and VO2max. Dyspnea will be assessed with the Modified Medical Research Council Scale; fatigue with the Fatigue Severity Scale; quality of life with the Scleroderma Health Assessment Questionnaire; physical activity level with the International Physical Activity Scale - Short Form

NCT Number	NCT06684132
Lead Sponsor	Firat University
Conditions	Scleroderma (Limited and Diffuse)
Enrollment	30 participants
Start Date	2024-11-10
Primary Completion	2025-01-10 (estimated)
Study Completion	2025-02-20 (estimated)
Updated on ClinicalTrials.gov	2024-11-12